Press release
Chronic Kidney Disease Competitive Landscape Report (Updated) | Boehringer Ingelheim, Eli Lilly, Reata Pharma, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharma, and others.
Chronic Kidney Disease Market
Key Takeaways from the Chronic Kidney Disease Competitive Landscape Report
• DelveInsight's Chronic Kidney Disease report depicts a robust space with 75+ Chronic Kidney Disease companies working to develop 95+ therapies for Chronic Kidney Disease treatment.
• The leading Chronic Kidney Disease Companies working in the market include Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharmaceuticals, SCOHIA PHARMA, DiaMedica Therapeutics, CinCor Pharma, Galapagos NV, Sentien Biotechnologies, Inc., Regeneron Pharmaceuticals, UnicoCell Biomed, OccuRx, Pharmicell, Lisata Therapeutics, Unicycive Therapeutics, Senda Biosciences, Sarfez Pharmaceuticals, Rege Nephro, Orgenesis, GNI Group, Algomedix, Maze Therapeutics, Chinook Therapeutics, Angion Biomedica Corp, Arch Biopartners, Scohia Pharma, Algernon Pharmaceuticals, TICEBA GmbH, and others.
• Promising Chronic Kidney Disease Therapies in the various stages of development include Roxadustat, Monofer®, AZD5718, Dapagliflozin 10 mg, MEDI8367, rHuEPO, AST-120, Epoetin Alfa, and others.
• December 2023: AstraZeneca announced a study of Phase 3 clinical trials for Dapagliflozin and Zibotentan/Dapagliflozin. This is a Phase III, randomised, multicentre, double-blinded study to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney disease (CKD) and high proteinuria.
• March 2023, POXEL SA, announced the publication of preclinical results in autosomal dominant polycystic kidney disease (ADPKD) for PXL770, a novel, first-in-class direct adenosine monophosphate-activated protein kinase (AMPK) activator. For the first time, POXEL SA showed beneficial effects of a direct and selective AMPK activator in preclinical ADPKD models from three species mouse, human, and dog. These results confirm the potential utility of AMPK activation for this disease and support the development of PXL770 in a Phase 2 clinical program for ADPKD.
• February 2023, AstraZeneca announced the successful completion of the acquisition of CinCor Pharma, Inc. The acquisition bolsters AstraZeneca's cardiorenal pipeline by adding baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure lowering in treatment-resistant hypertension, to its cardiorenal portfolio.
• January 2023, The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin) tablets, which is being investigated as a potential treatment to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease (CKD), Boehringer Ingelheim and Eli Lilly and Company announced
Request a sample and discover the recent advances in Chronic Kidney Disease Drugs @ Chronic Kidney Disease Competitive Landscape Report- https://www.delveinsight.com/report-store/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Chronic Kidney Disease report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Chronic Kidney Disease report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Chronic Kidney Disease Overview
Chronic Kidney Disease is a condition in which kidneys are damaged and cannot filter blood. As a result, extra fluid and waste from the blood remain in the body, potentially leading to various health issues like heart disease and stroke. Chronic Kidney Disease has various levels of seriousness.
Find out more about Chronic Kidney Disease Analytical Perspective: In-depth Commercial Assessment @ Chronic Kidney Disease Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Chronic Kidney Disease Companies and Therapies
• AstraZeneca: Forxiga
• Otsuka Pharmaceutical Co., Ltd.: JYNARQUE
• Boehringer Ingelheim: Empagliflozin
• KBP Biosciences: KBP-5074
• Bayer: Runcaciguat
• Regulus Therapeutics: RGLS8429
Chronic Kidney Disease Competitive Landscape
The Chronic Kidney Disease report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Chronic Kidney Disease Report Assessment
• Company Analysis
• Chronic Kidney Disease Therapeutic Assessment
• Chronic Kidney Disease Pipeline Assessment
• Inactive Chronic Kidney Disease Drugs Assessment
• Chronic Kidney Disease Unmet Needs
Learn more about the emerging Chronic Kidney Disease Competitive Landscape @ Chronic Kidney Disease Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Chronic Kidney Disease Report
• Coverage- Global
• Chronic Kidney Disease Companies- Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharmaceuticals, SCOHIA PHARMA, DiaMedica Therapeutics, CinCor Pharma, Galapagos NV, Sentien Biotechnologies, Inc., Regeneron Pharmaceuticals, UnicoCell Biomed, OccuRx, Pharmicell, Lisata Therapeutics, Unicycive Therapeutics, Senda Biosciences, Sarfez Pharmaceuticals, Rege Nephro, Orgenesis, GNI Group, Algomedix, Maze Therapeutics, Chinook Therapeutics, Angion Biomedica Corp, Arch Biopartners, Scohia Pharma, Algernon Pharmaceuticals, TICEBA GmbH, and others.
• Chronic Kidney Disease Therapies- Roxadustat, Monofer®, AZD5718, Dapagliflozin 10 mg, MEDI8367, rHuEPO, AST-120, Epoetin Alfa, and others.
• Chronic Kidney Disease Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Chronic Kidney Disease Product Developmental Activities, Visit @ Chronic Kidney Disease Research and Development Activities- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Chronic Kidney Disease: Overview
4. Chronic Kidney Disease -Analytical Perspective: In-depth Commercial Assessment
5. Chronic Kidney Disease Competitive Landscape
6. Chronic Kidney Disease Therapeutic Assessment
7. Chronic Kidney Disease: Company and Product Profiles (Marketed Therapies)
8. AstraZeneca
9. Forxiga
10. Chronic Kidney Disease: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Phase III)
12. KBP Biosciences
13. KBP-5074
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II)
16. Bayer
17. Runcaciguat
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. Regulus Therapeutics
21. RGLS8429
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. Maze Therapeutics
25. APOL1 Programme
26. Drug profiles in the detailed report…..
27. Inactive Products
28. Chronic Kidney Disease Unmet needs
29. Chronic Kidney Disease Market drivers and barriers
30. Appendix
For further information on the Chronic Kidney Disease Report @ Chronic Kidney Disease Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/chronic-kidney-disease-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Top Selling Market Research Reports in 2024
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Chronic Neuropathic Pain Market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Hydrocephalus Treatment Market- https://www.delveinsight.com/report-store/hydrocephalus-market
Cancer Therapy Market- https://www.delveinsight.com/report-store/cancer-therapy-market
Glaucoma Market- https://www.delveinsight.com/report-store/glaucoma-market
Methicillin-resistant Staphylococcus Aureus Mrsa Infection Market- https://www.delveinsight.com/report-store/methicillin-resistant-staphylococcus-aureus-mrsa-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Polycystic Ovarian Syndrome Market- https://www.delveinsight.com/report-store/polycystic-ovarian-syndrome-market
Radiodermatitis Market- https://www.delveinsight.com/report-store/radiodermatitis-market
Rhinosinusitis Market- https://www.delveinsight.com/report-store/rhinosinusitis-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
Wilms Tumor Market- https://www.delveinsight.com/report-store/wilms-tumor-market
Hidradenitis Suppurativa Market- https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
Uveitis Market- https://www.delveinsight.com/report-store/uveitis-market
Venous Thromboembolism Market- https://www.delveinsight.com/report-store/venous-thromboembolism-market
Beta Thalassemia Market- https://www.delveinsight.com/report-store/beta-thalassemia-market
Cold Agglutinin Disease Market- https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-market
Postpartum Depression Market- https://www.delveinsight.com/report-store/postpartum-depression-ppd-market
Radiation Dermatitis Market- https://www.delveinsight.com/report-store/radiation-dermatitis-market
Synovial Sarcoma Market- https://www.delveinsight.com/report-store/synovial-sarcoma-market
Tendinopathy Market- https://www.delveinsight.com/report-store/tendinopathy-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Diabetic Nephropathy Market- https://www.delveinsight.com/report-store/diabetic-nephropathy-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Pcsk9 Inhibitors Market- https://www.delveinsight.com/report-store/pcsk9-inhibitors-market
Respiratory Syncytial Virus Market- https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
Chemotherapy Induced Neutropenia Market- https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Immune Thrombocytopenia Market- https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Cystic Fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Post Operative Pain Management Market- https://www.delveinsight.com/report-store/post-operative-pain-management-market
Primary Biliary Cholangitis Market- https://www.delveinsight.com/report-store/primary-biliary-cholongitis-pbc-market
Progressive Supranuclear Palsy Market- https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
Membranous Nephropathy Market- https://www.delveinsight.com/report-store/membranous-nephropathy-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Diabetic Retinopathy Market- https://www.delveinsight.com/report-store/diabetic-retinopathy-market
Post Operative Pain Market- https://www.delveinsight.com/report-store/postoperative-pain-market
Genital Herpes Market- https://www.delveinsight.com/report-store/genital-herpes-market
Axillary Hyperhidrosis Market- https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Kidney Disease Competitive Landscape Report (Updated) | Boehringer Ingelheim, Eli Lilly, Reata Pharma, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharma, and others. here
News-ID: 3573278 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
